Receive our newsletter – data, insights and analysis delivered to you
  1. News
May 25, 2017

M&As this week: BarioSurg, Finesse Medical, Respirtech

Neurometabolic devices developer EnteroMedics has completed the acquisition of BarioSurg.

Neurometabolic devices developer EnteroMedics has completed the acquisition of BarioSurg.

The acquisition enables EnteroMedics to access the target company’s Gastric Vest System, which is a minimally invasive, laparoscopically implanted medical device being investigated for weight loss in morbidly obese patients.

EnteroMedics has paid $2m in cash, 1.38 million unregistered shares of its common stock, and one million unregistered shares of its conditional convertible preferred stock.

Finesse Medical has been acquired by Avery Dennison, as a part of its long-term strategic goal for industrial and healthcare materials segment.

Finesse Medical specialises in developing wound care and skin treatment products using advanced technologies, while Avery, through its business unit Vancive Medical Technologies, provides pressure-sensitive and functional materials for the retail apparel market.

"Finesse’s innovative portfolio of silicone gels and polyurethane foam dressings will complement Avery’s existing products in wound care, while it will also provide new global sales and distribution channels for Avery's products."

Finesse’s innovative portfolio of silicone gels and polyurethane foam dressings will complement Avery’s existing products in wound care, while it will also provide new global sales and distribution channels for Avery's products.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Royal Philips intends to acquire respiratory care products developer Respirtech to further expand its business unit, especially in the chronic obstructive pulmonary disease (COPD) segment.

The acquisition will strengthen Royal Philips’ respiratory care portfolio with the target company’s vest therapy solution and capabilities.

Tissue Regenix plans to purchase CellRight Technologies.

Based in Texas, US, CellRight is a biologics company specialising in the development of human osteoinductive and wound care scaffolds for use in general orthopaedic, dental and sports medicine surgical procedures.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU